ESC Premium Access

Effect of bivalirudin vs unfractionated heparin in transcatheter aortic valve implantation with balloon-expandable valves. The BRAVO-3 trial

Congress Presentation

About the speaker

Professor Axel Hp Linke

Heart Center - University Hospital Dresden, Dresden (Germany)
3 presentations
0 follower

18 more presentations in this session

Comparison of outcomes between nonagenarian and younger patients undergoing transcatheter aortic valve replacement (TAVR) with the LOTUS valve.

Speaker: Doctor S. Ramkumar (Melbourne, AU)


Transradial versus the transfemoral approach in alcohol septal ablation

Speaker: Doctor T. Lefevre (Massy, FR)


Long term follow up after transcatheter tricuspid valve-in-valve replacement using Edwards Sapien XT valve.

Speaker: Doctor R. Scarsini (Verona, IT)


5 years after percutaneous edge-to-edge mitral valve repair, what has happened?

Speaker: Mr F. Kortlandt (Nieuwegein, NL)


Is multiparametric FRANCE-2 score better than EuroSCORE II and STS PROM in predicting early mortality after transcatheter aortic valve implantation?

Speaker: Doctor J. Carmo (Carnaxide, PT)


Access the full session

Poster session 1 - Percutaneous structural heart interventions

Speakers: Professor A. Linke, Doctor S. Ramkumar, Doctor T. Lefevre, Doctor R. Scarsini, Mr F. Kortlandt...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb